Skip to content

ACET

Adicet Bio, Inc.

NASDAQ · USHealthcareBiotechnology
$7.89-2.83%

Price as of Jul 20, 2026

ACET capital

Adicet Bio, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.10x
Net debt / equity
-0.16x
Debt / assets
0.08x
Debt / EBITDA
-0.14x
Net debt / EBITDA
0.22x

Liquidity & coverage

Current ratio
7.65x
Quick ratio
7.65x
Cash ratio
7.52x
Interest coverage
EBITDA / interest
Working capital
$121.8M

Cash & dividend

FCF / debt
-6.59x
Cash flow / debt
-6.57x
Dividend per share
Dividend yield
Dividend growth 1y
+4.0%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.